MENU
URGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
UroGen Pharma (URGN) Ownership - Who owns UroGen Pharma?
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
400 Alexander Park Drive
Phone
+1 646 768-9780
Employees
201
Web
https://www.urogen.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
510.87M
P/E Ratio
N/A
Total Cash
195.89M
Projected Growth
N/A
Total Debt
124.95M
Revenue
91.87M
Risk (Beta)
0.04
Dividend Yield
N/A
Total Cash/Share
4.25
Total Debt/Equity
N/A
Revenue/Share
2.02 USD as % of share price
Fundamentals
URGN
Capitalization
511M
P/E Ratio
N/A
Risk (Beta)
0.04
Dividend Yield
N/A
Total Cash
196M
Total Cash/Share
4.25
Total Debt
125M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.02%
Revenue
91.9M
ROE
N/A
Book Value
-46.46M
P/B Ratio
16.23
Cash Flow
N/A
Earnings
-3.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
126K
Current Ratio
5.65
Current Revenue Per Employee
86555.55
Dividends Per Share - Security
N/A
EBITDA
-119.79M
Float
N/A
Float - Current
N/A
Gross Income Margin
88.50
Revenue To Assets
-61.77
Shares Held By Institutions
474M
Shares Outstanding - Current
46.1M
Total Liabilities
294M
Total Volume MTD
N/A
Value
-1
Gain YTD
4.038
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapies for urological pathologies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
400 Alexander Park Drive
Phone
+1 646 768-9780
Employees
201
Web
https://www.urogen.com